Financials

Discussions Technicals Seasonals

6827 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

MegaPro Biomedical Co., Ltd. engages in the development of drug ingredients related to nanoparticles and nanocell technology platforms. Its products include iron agent for iron deficiency in chronic kidney diseases, contrast agent for liver and lymph nodes magnetic resonance imaging, and anti-cancer drugs. The company was founded on November 7, 2014 and is headquartered in Hsinchu, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6827 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company